Showing posts with label 2018 - Conference on Retroviruses and Opportunistic Infections (CROI). Show all posts
Showing posts with label 2018 - Conference on Retroviruses and Opportunistic Infections (CROI). Show all posts

Friday, March 23, 2018

A serious liver ailment is stalking Kentucky's children. But they aren't getting care

A serious liver ailment is stalking Kentucky's children. But they aren't getting care
The Courier-Journal
A Courier Journal investigation found hepatitis C has skyrocketed among Kentucky births amid the state's raging drug epidemic, but attempts to prevent, track and control the infectious, curable disease have fallen short. That means many kids don't get the care they need, risking cirrhosis and liver cancer ...

Continue reading:

Of Interest
Webcast lecture presented at Conference on Retroviruses and Opportunistic Infections (CROI)
March 4 to March 7, 2018
Boston MA

Link - HCV Prevention and Treatment In Children
View all...

Friday, March 9, 2018

HCV Tx-as-Prevention Strategy Seems to Work in HIV+ MSM

Meeting Coverage MedPage Today > CROI

HCV Tx-as-Prevention Strategy Seems to Work in HIV+ MSM
by Molly Walker, Staff Writer, MedPage Today March 09, 2018
BOSTON -- Two trials successfully examined a "treatment as prevention" strategy for hepatitis C in mostly HIV-infected men who have sex with men (MSM), and were reported by researchers here. 
The first trial found that for hepatitis C virus (HCV)-infected MSM, a shorter 8-week course of grazoprevir/elbasvir, a direct-acting antiviral combination therapy for acute HCV infection was comparable to a 12-week treatment...

Meeting Coverage Across The Web:
Review key presentations presented at CROI
News, slidesets, interviews, and webinars

Monday, March 5, 2018

Meeting Coverage - Conference on Retroviruses and Opportunistic Infections CROI 2018

Conference on Retroviruses and Opportunistic Infections (CROI)
March 4 to March 7, 2018
Boston MA

HIV and ID Observations.
Paul Sax is Clinical Director of the HIV Program and Division of Infectious Diseases at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School.
Paul E. Sax, MD
March 11th, 2018
Really Rapid Review — CROI 2018, Boston
CROI clearly remains our best meeting, the only one that brings together so much high quality research from so many disciplines. Clinical, basic, and behavioral researchers all have a place here.
National AIDS Treatment Advocacy Project NATAP
Coverage @ NATAP
Jules Levin, Executive Director
Our web site is read all over the world and is recognized as a leading reliable source of HIV and Hepatitis treatment information for doctors, patients, and others. The information on the site is scientifically oriented, abundant, and comprehensive in its coverage of both HIV and Hepatitis. The site is regularly updated with new articles, studies and highlights from various major conferences.

Merck to Present New Data from Studies of Investigational HIV Therapies Doravirine and MK-8591 at CROI 2018
Begin here.....
Coverage @  Healio
Healio brings you the highlights from the Conference on Retroviruses and Opportunistic Infections (CROI). Refer back to this page often for the latest news from CROI, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

CROI chair: HIV conference promises to be ‘exciting meeting’
March 4, 2018
BOSTON — CROI 2018 Chair Judith S. Currier, MD, professor of medicine and division chief of infectious diseases at…
Begin here....
Coverage @ NAM aidsmap
We will be reporting on key research presented at the conference, publishing news online and sending out four conference news summary bulletins – three during the week of the conference and one the week after. The bulletins will be available in English, French, Spanish, Portuguese, Italian and Russian. You can sign up here to receive these email bulletins. (If you already receive NAM’s regular email bulletins, you will automatically receive our conference bulletins.)

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys
Liz Highleyman
Published: 05 March 2018
Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) this week in Boston.
Begin here...
Coverage @ Contagion
Contagion® will be providing exclusive coverage on the conference, and so, keep your eyes peeled for session coverage and interviews with some of the key presenters.

Harnessing the Power of International, Interdisciplinary Collaboration on the Quest to Cure HIV
International interdisciplinary collaboration will bring us that much closer to a cure for HIV.
MedPage Today
Coverage @ MedPage Today
MedPage Today, a CE and CME accredited medical news service, provides free continuing education to healthcare professionals in addition to the latest news.

Sex in Late-Stage Pregnancy Tied to Higher HIV Risk Biological changes may increase HIV transmission in serodiscordant couples 
BOSTON -- The risk of HIV transmission per sex act increased steadily through pregnancy, and was highest during postpartum, researchers reported here. In two HIV prevent studies that included 2,571 African women living in HIV serodiscordant relationships (female partners did not have HIV), the risk of HIV infection was 2.97-fold higher during the second two trimesters of pregnancy (P=0.01) and 4.18-fold higher during the 6-month post partum period (P=0.01), according to Renee Heffron, PhD, of the University of Washington in Seattle, and colleagues.
Begin here....
Clinical Care Options HIV
Coverage @ Clinical Care Options
Get up to date on the latest HIV data with rapid Capsule Summaries, downloadable slidesets, and live, expert-led Webinars covering key studies from Boston.

New Data from CROI 2018
Expert faculty members summarize key studies from this important annual conference.
Expert Review @ ViralEd
ViralEd, Inc. is a physician-directed medical education company whose mission is to provide thought-provoking, effective, and evidence-based CME to help improve health care provider knowledge and professional development. For over a decade, ViralEd's team of dedicated professionals have specialized in using a blended learning approach that combines innovative technology with live programming to provide programs and medical education content that is unique, timely, and of high quality.

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018). This program consists of three components: (1) CME Internet Symposium: CROI 2018 Expert Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) Rapid-Fire Review of CROI 2018: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (3) From Conference to Clinic: Reviewing and Applying Data From CROI 2018: case-based dinner meetings during which the key data are reviewed, discussed and applied to patient care.

The CME Internet Symposium: CROI 2018 Expert Review will feature a panel of HIV experts reviewing and discussing key presentations on antiretroviral therapy presented at CROI 2018. The review and discussion will focus on HIV therapeutic options and developments, including: current treatment and management strategies, algorithms and recommendations, therapies in development, epidemiology, and diagnosis and clinical management of specific patient populations. This activity will enable participating health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care. All online components of the program can be accessed at

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at CROI 2018 and it is not sanctioned by the organizers of CROI 2018.